India is known as the Pharmaceutical for the World. India has been developing Vaccines for more than 30 years. India has emerged as one of the leading manufacturers of vaccines worldwide, and supplies large quantities of basic and advanced vaccines across the globe – 60% of global vaccine.
So why is Pfizer withdrawing their application from the worlds 2nd largest population?
Did India ask the right question?
Was Pfizer unable to provide the required data? According to the article, Pfizer’s response was - " Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future.”
India's Central Drugs Standard Control Organisation had declined to accept Pfizer's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians
Isn’t this a requirement in most countries? To have a local trial on the vaccine safety and immunogenicity .
@kmwong8711 its hard to say depends on glove sentiment. Seems like price has been ranging at 1.10-1.20 during bad sentiment, but can jump to 1.30-1.60 when glove is trending....
If you are looking to make money next week and next month I recommend to take a look at Esceram. The guys at Serba Dinamik like Dato Karim and friends are buying huge amount of Esceram share since last week. It potentially could be the next KPower and SCIB. Dont miss the boat
According to Malaysian Rubber Glove Manufactuters Association (MARGMA), global glove demand is about 330 billion pieces per year & estimated to grow at 10% annually
For 2021 global glove demand is expected to grow to 396 billion pieces versus the total production capacity of Malaysian glove factories of 280 billion pieces
While for 2022 global glove demand is expected to expand further to 475 billion pieces against the projected total production capacity of Malaysian glove factories of 363 billion pieces
While also, a research analyst from a local IB has also written that covid-19 vaccine deployment could in fact add another further new demand source of 18 billion pieces per year, assuming that 60% of the world's 7.5 billion people gets their vaccine in two doses annually
Today, the demand for rubber gloves is so overwhelming that major rubber glove manufacturers have an order waiting list of more than 12 months, a few extending to twenty four months, some up to even thirty six months
After being red for many days , share price of most gloves stocks are severely low for not to at least technically rebound. Dont expect for ATH or parabolic move again but atleast have a day or few days show. sectors in show are in rotational basis, healthcare alone already RED for so many days but we are still in the middle of pandemic, so weird. Thus, let us hope hc rockets starting engine tomorrow or very soon.
Fourteen residents at a German nursing home have tested positive despite receiving two vaccine doses.
Local officials in the district of Osnabruck, Germany, said there was an outbreak of the UK variant of coronavirus at a nursing home in Belm. The outbreak came despite all of its residents already receiving two doses of the BioNTech-Pfizer vaccine, with their last shot on January 25. A local government spokesperson said 14 residents tested positive for the virus at the end of last week So it seemed that the Pfizer vaccine even after 2 doses is not effective against the UK Virus Variant.
Is the Vaccination program failing?
Why did Pfizer pull out from India, the World’s 2nd largest population when India requested for trial. ?
The country now reports 944 cases of variants that spread more easily, bypass treatments and immunities, or both
Tuesday night's report still shows three known cases of P.1, a variant first spotted in Brazil that appears to bypass immunities, and now nine cases of B.1.351, a variant that took over South Africa and resists some treatments and vaccines
Johnson & Johnson CEO says he thinks people will need an annual Covid-19 vaccine for many years to come The Chief Executive Officer of Johnson & Johnson said Tuesday that people may need an annual Covid-19 shot for many years to come in order to be protected against variants of the virus.
“Unfortunately, as (the virus) spreads it can also mutate,” Alex Gorsky told CNBC’s Meg Tirrell Tuesday during the network’s Healthy Returns Spotlight event. “Every time it mutates, it’s almost like another click of the dial so to speak where we can see another variant, another mutation that can have an impact on its ability to fend of antibodies or to have a different kind of response not only to a therapeutic but also to a vaccine.”
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!
MQ Trader 365 views | 10 d ago
0:17
New IPO: O&G healthcare service provider, Metro Healthcare Berhad aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
mingtee3
66 posts
Posted by mingtee3 > 2021-02-05 13:03 | Report Abuse
M heavily invested.....don’t die now.....